Bailing for Neurocrine

Quote



I don't know why anyone would go to Neurocrine. I don't know many of their other drugs bur looked their 3rd qtr shareholder report. It's on track to be a $1.1 billion a year drug. Their competitor austedo is $850 million. That's about 20%. Then you look at the Ingrezza AE profile on the FDA website and you scratch your head. Ingrezza is A very dirty drug. When you look at the two on the fda website ingrezza has 8x more deaths then austedo and around 20x more serious AEs. So, I think that's why Neurocrine stock is not moving north with the expansion of their sales force. We'll, that and austedo has orphan drug status on HD until March 2023. Based on what I read here with how unhappy Neurocrine reps are, this company does not look like a good investment.
 


anonymous said:
I don't know why anyone would go to Neurocrine. I don't know many of their other drugs bur looked their 3rd qtr shareholder report. It's on track to be a $1.1 billion a year drug. Their competitor austedo is $850 million. That's about 20%. Then you look at the Ingrezza AE profile on the FDA website and you scratch your head. Ingrezza is A very dirty drug. When you look at the two on the fda website ingrezza has 8x more deaths then austedo and around 20x more serious AEs. So, I think that's why Neurocrine stock is not moving north with the expansion of their sales force. We'll, that and austedo has orphan drug status on HD until March 2023. Based on what I read here with how unhappy Neurocrine reps are, this company does not look like a good investment.
Click to expand...
And they play the we’re not big Pharm game but we treat our reps just like big Pharm.
 


anonymous said:
I don't know why anyone would go to Neurocrine. I don't know many of their other drugs bur looked their 3rd qtr shareholder report. It's on track to be a $1.1 billion a year drug. Their competitor austedo is $850 million. That's about 20%. Then you look at the Ingrezza AE profile on the FDA website and you scratch your head. Ingrezza is A very dirty drug. When you look at the two on the fda website ingrezza has 8x more deaths then austedo and around 20x more serious AEs. So, I think that's why Neurocrine stock is not moving north with the expansion of their sales force. We'll, that and austedo has orphan drug status on HD until March 2023. Based on what I read here with how unhappy Neurocrine reps are, this company does not look like a good investment.
Click to expand...

Same bitter loser who posts this on every Neurocrine thread. Beat it loser.
 


anonymous said:
Same bitter loser who posts this on every Neurocrine thread. Beat it loser.
Click to expand...

That is why you are in trouble. Managers like you are not responding to the question. You are just insulting the messenger/prescriber who looked up our drug on the FDA website. Unless our strategy is to convince prescribers to not look up Ingrezza's AE profile on the FDA website? That is just as stupid a strategy as not answering the question.
 


Amazing product, gifted and talented management that takes the time to train and mentor. How many companies can show you a Director of Human Resources that begin as a temporary receptionists?

The company is overflowing with amazing stories just like that. Improbable success stories.
 


anonymous said:
Amazing product, gifted and talented management that takes the time to train and mentor. How many companies can show you a Director of Human Resources that begin as a temporary receptionists?

The company is overflowing with amazing stories just like that. Improbable success stories.
Click to expand...


Are you talking about Neurocrine or Acadia?
 






anonymous said:
Amazing product, gifted and talented management that takes the time to train and mentor. How many companies can show you a Director of Human Resources that begin as a temporary receptionists?

The company is overflowing with amazing stories just like that. Improbable success stories.
Click to expand...
Easy. Most companies are woke and will any woman over the most qualified dude. Elon would not be hired now , they would hire a biimbo pillow
 









Write your reply...
Top Bottom
Back
Quote